IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SALVI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.533
EU - Europa 5.023
AS - Asia 3.816
SA - Sud America 798
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 13
AN - Antartide 1
Totale 15.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.386
PL - Polonia 1.411
CN - Cina 1.280
SG - Singapore 1.225
DE - Germania 1.022
BR - Brasile 676
UA - Ucraina 667
IT - Italia 572
HK - Hong Kong 341
FI - Finlandia 304
VN - Vietnam 288
GB - Regno Unito 255
RU - Federazione Russa 237
IN - India 220
FR - Francia 171
TR - Turchia 162
IE - Irlanda 106
SE - Svezia 88
CA - Canada 84
ID - Indonesia 64
AR - Argentina 49
BD - Bangladesh 49
BE - Belgio 47
MX - Messico 44
AT - Austria 28
ZA - Sudafrica 26
IQ - Iraq 25
ES - Italia 23
NL - Olanda 23
JP - Giappone 22
EC - Ecuador 20
RO - Romania 20
EU - Europa 17
PK - Pakistan 14
PY - Paraguay 13
AU - Australia 12
IR - Iran 12
KE - Kenya 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
KR - Corea 11
CO - Colombia 10
CZ - Repubblica Ceca 10
JO - Giordania 9
CL - Cile 8
LT - Lituania 8
MA - Marocco 8
OM - Oman 8
AZ - Azerbaigian 7
TH - Thailandia 7
UZ - Uzbekistan 7
IL - Israele 6
MU - Mauritius 6
UY - Uruguay 6
VE - Venezuela 6
LY - Libia 5
PE - Perù 5
TN - Tunisia 5
BO - Bolivia 4
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
JM - Giamaica 4
KZ - Kazakistan 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MY - Malesia 3
RS - Serbia 3
TW - Taiwan 3
AL - Albania 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
SD - Sudan 2
TJ - Tagikistan 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
IM - Isola di Man 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
Totale 15.265
Salva come PNG Salva come JPEG
Città #
Warsaw 1.409
Singapore 573
Ashburn 457
Jacksonville 452
Fairfield 378
Chandler 361
Hong Kong 334
Woodbridge 311
Beijing 309
Ann Arbor 276
Houston 209
Brescia 203
New York 201
Princeton 196
Helsinki 185
Wilmington 183
Nanjing 169
Cambridge 164
Los Angeles 161
Seattle 142
Istanbul 113
The Dalles 112
Dublin 106
Munich 104
Ho Chi Minh City 89
Dearborn 87
Des Moines 80
Buffalo 79
Chicago 72
Dong Ket 70
Dallas 63
São Paulo 63
Shanghai 54
Nanchang 53
San Francisco 53
Changsha 52
Milan 52
Shenyang 50
Jakarta 46
Jinan 46
Moscow 46
Brussels 45
Hebei 42
Lancaster 40
Tianjin 39
Redondo Beach 38
Pune 37
Hanoi 36
Jiaxing 32
Santa Clara 31
Brooklyn 27
Toronto 27
Turku 27
Kunming 25
Salt Lake City 25
San Diego 25
Kocaeli 24
Rio de Janeiro 24
Lappeenranta 22
Council Bluffs 21
Hangzhou 21
Mexico City 21
Nuremberg 20
Montreal 19
Phoenix 19
Guangzhou 18
London 18
Nürnberg 18
Tokyo 18
Boston 17
Johannesburg 17
North York 17
Zhengzhou 17
Ningbo 16
Orem 16
Boardman 15
Verona 15
Chennai 14
Denver 14
Poplar 14
Tampa 14
Vienna 14
Atlanta 13
Belo Horizonte 13
Rome 13
Da Nang 12
Romola 12
Stockholm 12
Bari 11
Charlotte 11
Manchester 11
Amsterdam 10
Ankara 10
Elk Grove Village 10
Falkenstein 10
Frankfurt am Main 10
Nairobi 10
Porto Alegre 10
Amman 9
Curitiba 9
Totale 9.318
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 341
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 324
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 314
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 267
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 266
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 255
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 238
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 230
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 217
Functional Role of microRNA-23b-3p in Cancer Biology 217
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 209
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 198
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 197
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 195
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 191
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 190
Biological Function of MicroRNA193a-3p in Health and Disease 189
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 185
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 179
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 175
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 174
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 170
microRNAs and human hepatocellular carcinoma 167
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 162
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 156
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 155
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 152
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 152
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 151
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 150
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 150
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 147
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 143
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 142
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 142
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 142
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 141
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 138
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 135
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 133
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 132
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 131
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 127
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 126
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 126
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 125
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 122
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 122
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 122
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 120
Urokinase and c-met are target of miR-23b in human cells. 116
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 116
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 116
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 115
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 113
DNA methylation variations in familial female and male breast cancer 113
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 111
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 109
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 109
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 108
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 107
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 107
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 106
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 105
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 103
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 102
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 101
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 100
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 100
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 100
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 100
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 99
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 99
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 99
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 99
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 98
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 98
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 98
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 97
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 97
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 96
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 96
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 95
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 94
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 94
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 93
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 92
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 92
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 91
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 91
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 90
RNA interference for urokinase gene in human hepatocellular carcinoma 89
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 87
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 87
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 86
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 85
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 84
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 84
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 82
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 81
Totale 13.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.089 0 0 0 0 0 182 68 194 229 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/20252.739 37 50 49 384 216 240 199 74 332 144 663 351
2025/20263.163 475 668 379 744 527 370 0 0 0 0 0 0
Totale 15.543